Evidence: Public Summary

Our preclinical program includes both in vitro (cell culture) and in vivo (animal model) studies examining the effects of GLA on glioma cells. Laboratory findings have informed our understanding of potential mechanisms and supported advancement toward IND-enabling studies.

• Cell culture studies examining effects on glioma cell lines
• Animal model studies with local GLA administration
• Mechanistic studies exploring lipid peroxidation pathways
• Comparative studies with normal brain tissue

Historical observations in patients were conducted prior to current regulatory frameworks. These limited, non-randomized observations documented individual patient experiences but do not meet modern clinical trial standards.

• Historical case observations documented over time
• Limited patient numbers with varying conditions
• Non-randomized, open-label design
• Variable individual responses observed

Safety evaluation is a critical component of our IND-enabling program. Preclinical toxicology studies are designed to characterize the safety profile of local GLA administration.

• GLP toxicology studies planned/ongoing
• Local tissue effects assessment
• Systemic exposure evaluation
• Safety monitoring protocols in development